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Abstract
It is hypothesized that a fundamental function of sleep is to restore an individual’s day-to-day 
ability to learn and to constantly adapt to a changing environment through brain plasticity. Brain-
derived neurotrophic factor (BDNF) is among the key regulators that shape brain plasticity. 
However, advancing age and carrying the BDNF Met allele were both identified as factors that 
potentially reduce BDNF secretion, brain plasticity, and memory. Here, we investigated the 
moderating role of BDNF polymorphism on sleep and next-morning learning ability in 107 
nondemented individuals who were between 55 and 84 years of age. All subjects were tested with 
1 night of in-laboratory polysomnography followed by a cognitive evaluation the next morning. 
We found that in subjects carrying the BDNF Val66Val polymorphism, consolidated sleep was 
associated with significantly better performance on hippocampus-dependent episodic memory 
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tasks the next morning (β-values from 0.290 to 0.434, p ≤ 0.01). In subjects carrying at least one 
copy of the BDNF Met allele, a more consolidated sleep was not associated with better memory 
performance in most memory tests (β-values from −0.309 to −0.392, p values from 0.06 to 0.15). 
Strikingly, increased sleep consolidation was associated with poorer performance in learning a 
short story presented verbally in Met allele carriers (β = −0.585, p = 0.005). This study provides 
new evidence regarding the interacting roles of consolidated sleep and BDNF polymorphism in the 
ability to learn and stresses the importance of considering BDNF polymorphism when studying 
how sleep affects cognition.
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Introduction
There is strong evidence supporting the fundamental role of sleep in brain plasticity, 
memory, and learning (Diekelmann and Born, 2010). Sleep facilitates the consolidation of 
new information or abilities learned the previous day (Walker et al., 2002; Peigneux et al., 
2004). The characteristics of sleep also predict the ability to learn new material after the 
sleep episode (Mander et al., 2011; Lafortune et al., 2014), and total sleep deprivation 
impedes subsequent encoding in episodic memory (Drummond et al., 2000; Yoo et al., 
2007). The synaptic homeostasis hypothesis suggests that in response to learning, synaptic 
potentiation increases in the cortex and the hippocampus during wakefulness, which 
eventually saturates the ability to learn (Tononi and Cirelli, 2014). The same authors 
proposed that sleep—particularly slow-wave activity (SWA) occurring during non-rapid eye 
movement (NREM) sleep—restores the ability to learn by depressing synaptic strength. 
Suppression of SWA before learning was shown to affect hippocampal activity and next-day 
memory even when total sleep time is not reduced (Van Der Werf et al., 2009, 2011).
Sleep consolidation is another sleep characteristic that plays a major role in memory and 
synaptic plasticity. Rodent studies suggest that sleep fragmentation, independently of sleep 
duration, impairs long-term potentiation and the ability to learn (Tartar et al., 2006; Wallace 
et al., 2015). Moreover, a minimal unit of uninterrupted sleep, or sleep bout, is necessary to 
improve next-day learning (Rolls et al., 2011).
The availability of brain-derived neurotrophic factor (BDNF), a secretory peptide, is crucial 
for synaptic plasticity (Kang and Schuman, 1995). BDNF is released in response to neural 
activity and plays a key role in activity-dependent synaptic strengthening (Korte et al., 
1995). One factor that intrinsically modulates the availability of BDNF in the human brain is 
the rs6265 single nucleotide polymorphism in the BDNF gene. In Caucasians, 25–35% of 
the population carries a valine (Val) to methionine (Met) substitution at codon 66 (referred to 
as Met carriers) and has reduced activity-dependent BDNF secretion compared with 
homozygous BDNF Val allele carriers (referred to as Val/Val carriers; Egan et al., 2003). 
Several studies have linked reduced BDNF secretion in Met carriers with lower synaptic 
plasticity and poorer memory (Baj et al., 2013), although significant inconsistencies exist 
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(Mandelman and Grigorenko, 2012). In comparison with Val/Val carriers, it was suggested 
that Met carriers experience growing impairment on memory tasks as they age (Kennedy et 
al., 2015), making the aging population particularly appealing to understanding how the 
BDNF Met allele affects memory.
It is unknown whether sleep and BDNF polymorphism interact to predict the ability to 
encode new episodic memory the next morning. The present study aims to ascertain whether 
BDNF polymorphism moderates the association between sleep (more specifically, NREM 
SWA, and sleep consolidation) and performance on subsequent episodic declarative memory 
tasks. Given that sleep plays a crucial role in memory and synaptic plasticity, and that the 
BDNF Met allele was shown to reduce brain plasticity, we hypothesized that the positive 
effect of sleep on new learning the next morning would be significantly reduced among Met 
carriers compared with Val/Val carriers.
Materials and Methods
Subjects
A total of 107 middle-aged and older nondemented adults (88 men and 19 women) between 
55 and 84 years of age took part in this study. Seventy-nine subjects carried the wild-type 
Val66Val polymorphism (Val/Val carriers), while 28 subjects carried at least one copy of the 
Met allele (Met carriers), representing 26.2% of our study sample (Table 1, subject 
characteristics). Among the Met carriers, 27 participants carried one BDNF Met allele and 
one participant carried the BDNF Met66Met polymorphism. This study was part of a 
longitudinal study on aging, cognition, and obstructive sleep apnea. Subjects were recruited 
from the waiting list of a sleep apnea clinic at Hôpital du Sacré-Coeur de Montréal and 
through the media. Twenty-four of the 79 Val/Val subjects (30%) were recruited from the 
waiting list of the sleep apnea clinic versus 9 of the 28 Met carriers (32%). No significant 
difference was found between the two groups in the proportion of participants recruited 
through the sleep apnea clinic versus through the media (χ2 = 0.03, p = 0.86). Our exclusion 
criteria were as follows: diagnosis of dementia based on a medical examination and 
according to established criteria (American Psychiatric Association, 2013); a score of <24 
on the Mini Mental State Examination (Folstein et al., 1975); a score of <21 on the Montreal 
Cognitive Assessment (Nasreddine et al., 2005); diagnosis of a sleep disorder other than 
obstructive sleep apnea (e.g., narcolepsy, insomnia, rapid-eye movement (REM) sleep 
behavior disorder, restless leg syndrome); morbid obesity, defined as a body mass index of 
>40 kg/m2; a history of head injury, stroke, encephalopathy, psychiatric or neurological 
disease, chronic obstructive pulmonary disease, use of psychotropic medications (including 
drugs or alcohol abuse) that can influence sleep or cognition; use of continuous positive air 
pressure; and the presence of electroencephalographic anomalies suggestive of epilepsy. All 
participants gave written consent to participate in the study, and the hospital ethics 
committee approved the study. Subjects were compensated financially for participating.
Procedure
The protocol included a blood sample for genetic profiling, brain magnetic resonance 
imaging (MRI) acquisition to control for hippocampal volume, and an in-laboratory 
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polysomnography (PSG) followed by neuropsychological assessment the next morning. 
Participants’ size and weight were measured in the laboratory. Vascular risk factors were 
assessed using the Vascular Burden Index, a questionnaire that screens for hypertension, 
hypotension, hypercholesterolemia/dyslipidemia, coronary disease (angina pectoris, 
myocardial infarction, coronary artery bypass), transient ischemic attacks, diabetes, 
arrhythmias, and carotid stenosis based on previous medical observations (Villeneuve et al., 
2009). All subjects filled out the following questionnaires to ensure that groups were not 
different in terms of mood and sleep complaints: the Beck Depression Inventory, second 
edition (Beck et al., 1996); the Beck Anxiety Inventory (Beck and Steer, 1993); the 
Pittsburgh Sleep Quality Index (Buysse et al., 1989); the Epworth Sleepiness Scale (Johns, 
1991); and the Insomnia Severity Index (Bastien et al., 2001). Finally, all subjects filled out 
questionnaires on memory complaints (Self-Evaluation Questionnaire; Van Der Linden et 
al., 1989; Clément et al., 2008) and subjective cognitive complaints (Cognitive Failure 
Questionnaire; Broadbent et al., 1982).
Polysomnographic recording
Subjects were tested with 1 night of in-laboratory PSG recording that began between 9:22 
P.M. and 12:18 A.M. and ended between 5:40 and 8:36 A.M. the next morning, depending 
on each participant’s regular sleep schedule. Sleep was recorded using a 17-channel 
montage (Fz, F3, F4, F7, F8, Cz, C3, C4, T7, T8, Pz, P3, P4, P7, P8, O1, and O2) using the 
international 10–20 system with a linked mastoid reference. A Grass Technologies Model 
15A54 Polygraph (amplifier gain, 7.5 μV/mm; bandpass filter, 0.3–100 Hz) was used for 
recording, and all signals were digitized at a sampling rate of 256 Hz using commercial 
software (Harmonie, Natus). PSG included an electrooculogram, a submental 
electromyogram, and an electrocardiogram. Periodic leg movements were measured using 
an electromyogram of the bilateral anterior tibialis muscles. Thoracoabdominal strain 
gauges, oronasal thermistors, and oronasal cannula were used to monitor respiration, and a 
transcutaneous finger pulse oximeter was used to measure oxygen saturation.
Neuropsychological assessment
All neuropsychological assessments were performed in the morning following the PSG 
recording and started at ~9:00 A.M. They included the following two episodic memory 
tasks: the Rey Auditory Verbal Learning Test (RAVLT; Rey, 1941); and the Logical Memory 
subtest of the Wechsler Memory Scale, third edition (Wechsler, 1997).
In the RAVLT, participants heard the same list of 15 common words five times. Each time, 
immediately after listening to the list, the subjects were asked to repeat as many words as 
they could recall. A second list of 15 words was then presented, followed by an immediate 
recall of the first list of words. A fixed battery of other cognitive tests that did not involve 
learning verbal material was administered for ~20 min after the immediate recall. After this 
period, participants were asked to recall the first list of words they learned. In the present 
study, we used the total number of correctly recalled words for the five learning trials as well 
as the number of correctly recalled words for delayed recall.
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We also used the immediate and 30 min delayed recalls of Story A, a short story presented 
verbally to participants, which is part of the Logical Memory subtest. We administered a 
modified version of the Logical Memory subtest in which Story A is presented, followed by 
an immediate recall and an immediate recognition task. After a 30 min period during which 
nonverbal tests were presented, participants were asked to recall Story A. In this modified 
version, Story B was not presented to reduce interference. Scores for immediate and delayed 
recalls were calculated separately by summing the number of correct story items reported by 
the participant for each recall.
Other neuropsychological tests administered were the Continuous Performance Test (Beck 
et al., 1956), the Digit Span subtest of the Wechsler Adult Intelligence Test, third edition 
(Wechsler, 1997), semantic and alphabetic fluency (Benton et al., 1994), the Trail Making 
Test (Reitan, 1958), the Color-Word Interference Test of the Delis-Kaplan Executive 
Function System (Delis et al., 2001), and the Tower of London Test (Culbertson and Zillmer, 
1998). Neuropsychological tests were administered and scored blinded to the BDNF 
polymorphism group.
MRI acquisition
MRI acquisition was performed for 44 Val homozygotes and 16 Met allele carriers; other 
subjects were excluded from this part of the protocol due to MRI contraindications (i.e., 
orthopedic materials, pacemakers, or coronary stents) or claustrophobia. We used a 
Magnetom TRIO 3 tesla MRI scanner (Siemens Healthcare) with a three-dimensional T1-
weighted MPRAGE Turbo Flash multiecho system acquired with the following parameters 
of the Massachusetts General Hospital (Boston, MA): TR, 2530 ms; TE, four echo times: 
1.64, 3.50, 5.36, and 7.22 ms; matrix size, 256 × 256; FOV, 256 × 256; voxel size, 1.0 mm 
isotropic; flip angle, 7°; and 176 sagittal orientations.
Data analysis
Sleep—Sleep stages and events were scored according to the American Academy of Sleep 
Medicine Manual (Iber et al., 2007) by a trained medical electrophysiology technologist 
(H.B.). Sleep variables were calculated for the nocturnal sleep period (i.e., time from sleep 
onset through last epoch of sleep). The following variables were derived: total sleep time, 
sleep efficiency (percentage of time asleep during the sleep period), number of awakenings, 
and percentage of each sleep stage. We also analyzed the longest sleep bout during the sleep 
period as a measure of sleep consolidation. All sleep stages were considered in sleep bout 
measurement, with the exclusion of sleep bouts consisting solely of stage N1 sleep. The end 
of a sleep bout was determined by the occurrence of an epoch of wake. For the longest sleep 
bouts, 55.6% included both NREM and REM sleep, whereas 44.4% included only NREM 
sleep. To derive a single measure of sleep consolidation, a principal component analysis 
(PCA) with a varimax rotation was performed on the following variables: sleep efficiency, 
number of awakenings, and longest sleep bout. These three variables were selected because 
they were highly correlated (absolute r values ranging from 0.28 to 0.47; p values ranging 
from 0.002 to <0.000001). Only one significant component was obtained with PCA; it 
explained 58.9% of the variance and was used as the “sleep consolidation index,” with a 
higher index representing better sleep consolidation. The component matrix showed that the 
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three sleep variables included in the PCA highly correlated with the component extracted 
(absolute r values ranging from 0.70 to 0.83).
An apneic episode was defined as a total cessation of airflow lasting ≥10 s. A hypopneic 
episode was defined as a reduction in airflow of at least 30% from baseline lasting ≥10 s and 
accompanied by an oxygen desaturation of at least 3% or accompanied by an episode of 
arousal. The sum of the apnea and hypopnea episodes divided by the number of hours of 
sleep provides the apnea–hypopnea index.
Spectral analysis for NREM (stages N2 and N3) SWA (0.6–4 Hz) was performed on 5 s 
artifact-free sections using a fast Fourier transform (cosine tapering) and commercial 
software (Stellate Systems) to compute SWA (0.6–4 Hz) on F3 electrode. Epochs containing 
artifacts were considered as missing data to preserve sleep continuity. All-night NREM 
SWA was calculated for each subject and was averaged on 30 s epochs. Three Val/Val allele 
carriers and two Met allele carriers were excluded from the SWA analysis because they had 
significant artifacts on the F3 electrode, impeding spectral analyses.
BDNF genotyping—Genomic DNA was extracted from buffy coat using the Qiagen EZ1 
DNA kit. Genotype profiling of the BDNF rs6265 (Val66Met) polymorphism was conducted 
through PCR followed by pyro-sequencing. A PCR approach was used for amplification 
with the following primer pairs: forward biotin, 5′-GGACTCTGGAGAGCGTGAAT-3′; 
and reverse, 5′-CCGAACTTTCTGGTCCTCATC-3′. Genomic DNA (250–500 ng) was 
amplified with 10 pM of each primer, 1× PCR buffer kit (Qiagen), 0.4 mM deoxynucleotide 
(dNTP), 1.0 mM MgCl2, and 0.01 U of Taq polymerase (Qiagen). A Biometra TProfessional 
Basic thermocycler was used for amplification with the following conditions for 35 cycles: 
30 s at 95°C, 30 s at 61.2°C, and 1 min at 72°C. These 35 amplification cycles were 
preceded by a 2 min hot start at 95°C followed by a final 4 min extension to the last cycle at 
72°C. PCR products were visualized on a 1.2% agarose gel. The Val66Met polymorphism 
was subsequently determined via an established pyrosequencing protocol with oligo 
sequencing 5′-GCTGACACTTTCGAACA-3′ (Baj et al., 2013). The analyzed sequence 
was as follows: CA/GTGATAGAA-GAG. BDNF genotypes were validated on a subsample 
of 45 participants using TaqMan assay number C_11592758_10 on a Viia7 Real-Time 
Cycler (Life Technologies).
Apolipoprotein E ε4 allele genotyping—Apolipoprotein E ε4 allele (APOE4) 
genotyping was conducted to evaluate the proportion of individuals carrying the APOE4, a 
well known risk factor for Alzheimer’s disease (Poirier, 2003). This variable contributed to 
ensure that our two groups were equivalent in the proportion of individuals susceptible to 
present preclinical dementia. Genomic DNA was extracted from buffy coat using the Qiagen 
EZ1 DNA Kit. Genotype profiling of ApoE 112/158 single nucleotide polymorphisms 
(which determine the E2, E3, and E4 isoforms) was performed through PCR followed by 
pyrosequencing. A PCR approach was used for amplification with the following primer 
pairs: ApoE 112: forward, 5′-ACGGCTGTCCAAGGAGCTG-3′, and reverse, biotin 5′-
CACCTCGCCGCGGTACTG-3′; and ApoE 158: forward, 5′-
CTCCGCGATGCCGATGAC-3′, and reverse, biotin 5′-CCCCGGCCTGGTACACTG-3′. 
Genomic DNA (250–500 ng) was amplified with 20 pM each primer, 1× PCR buffer kit 
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(Qiagen), 0.4 mM dNTP, 1.0 mM MgCl2, DMSO, and 0.01 U of Qiagen Taq polymerase. A 
Biometra TProfessional Basic Thermocycler was used for amplification with the following 
conditions for 35 cycles: 30 s at 95°C, 30 s at 58.6°C, or 58.1°C for ApoE 112 or 158 
respectively, and 1 min at 72°C. These 35 amplification cycles were preceded by a 2 min hot 
start at 95°C and were followed by a final 4 min extension to the last cycle at 72°C. PCR 
products were visualized on a 1.2% agarose gel. The polymorphisms were subsequently 
determined via an established pyrosequencing protocol with oligo sequencing for ApoE112 
(5′-CGGACATGGAGGACG-3′) and ApoE 158 (5′-CGATGACCTGCAGAAG-3′). The 
analyzed sequence was as follows: TGT/CGCGGCCGCCT for ApoE112 and T/CGCCTG 
GCAG for ApoE158.
Hippocampal volume measurement
Hippocampal volume was measured as a control procedure to ensure that our two groups 
were equivalent. Using FreeSurfer Image Analysis Suite version 5.3.0. (Laboratory for 
Computational Neuroimaging, Center for Biomedical Imaging, Charlestown, MA), a 
volumetric segmentation of all subcortical structures was performed on individual T1-
weighted images. This process has been extensively described in previous studies (Fischl et 
al., 2002, 2004), and the FreeSurfer image analysis suite is documented and available on-
line. Briefly, this volume-based subcortical stream consists of automated steps that include 
the removal of non-brain tissue, an automated Talairach transformation, and a volumetric 
segmentation and labeling of subcortical structures. All the individual processed images 
were visually inspected to assess the quality of the segmentation, and left and right 
hippocampal volumes were extracted. Hippocampal volume was measured to describe the 
BDNF polymorphism groups.
Statistical analyses
Statistical analyses were conducted using SPSS for Mac version 20.0 (SPSS Science). 
Differences between BDNF polymorphism groups on demographic, neuropsychological, 
neuroimaging, and sleep variables were measured using Student’s t tests or χ2 tests, 
depending on the type of variable. The hypothesis that the BDNF polymorphism would 
interact with all-night NREM SWA (0.6–4.0 Hz) and the sleep consolidation index to predict 
memory performance the next morning was tested using eight hierarchical linear 
regressions. More specifically, we tested whether BDNF polymorphism is a moderating 
variable that affects the direction and/or the strength of the relation between independent 
variables (i.e., NREM SWA and sleep consolidation) and dependent variables (i.e., 
performance in the memory tests; Baron and Kenny, 1986). Four memory variables were 
used: for RAVLT, (1) the number of correctly recalled words in learning trials and (2) 
delayed recall; and for the Logical Memory subtest, Story A (3) immediate recall and (4) 
delayed recall. Control variables included in the hierarchical linear regressions were age, 
sex, number of years of education, and time with oxygen saturation <90% during sleep. 
They were selected because of their possible association with performance on episodic 
memory tasks (Rönnlund et al., 2005; Morrell and Twigg, 2006). Control variables (age, sex, 
education, and oxygen desaturation during sleep) and independent variables were all mean 
centered for regression analyses. Control variables were entered in the analysis in step 1. 
BDNF polymorphism and sleep variables were entered in step 2, while the interaction 
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between BDNF polymorphism and sleep variables was entered in step 3. Four hierarchical 
linear regressions were performed for each sleep variable, namely, NREM SWA and the 
sleep consolidation index. Correlations among the continuous predictor variables of the 
study (age, education, time with oxygen saturation <90%, NREM SWA power, and sleep 
consolidation index) were examined and showed no to moderate correlations, ranging from r 
= −0.02, p = n.s. to r = −0.24, p < 0.05. These low r values indicate that multi-collinearity 
was unlikely. The Bonferroni correction was applied for these eight models, and significance 
was set at p < 0.00625. Outliers were defined by standardized residuals (z scores) of >3.29 
or <3.29 (Tabachnick and Fidell, 2001), and, therefore, data from one Val/Val individual 
were excluded from one hierarchical regression. Significant interactions were tested using 
procedures previously described (Aiken and West, 1991), and fitted regression lines were 
plotted for each level of the dichotomous moderator (i.e., BDNF polymorphism) with an 
adjusted individual data point.
Control analyses were performed using hierarchical linear regressions with total sleep time 
as an independent variable to verify whether BDNF polymorphism moderates the 
association between sleep duration and next-morning learning ability. To verify whether the 
moderating effect of BDNF polymorphism on sleep was specific to declarative episodic 
memory, we performed additional hierarchical linear regression analyses on the other 
neuropsychological tests administered.
Results
No effect of BDNF polymorphism on demographic, neuroimaging, sleep, and 
neuropsychological variables
No between-group differences were observed for age, sex ratio, education level, body mass 
index, hippocampal volume, proportion of subjects carrying the APOE4, and vascular 
burden index (Table 1). Our sample consisted mainly of men (78.4% of Val/Val carriers and 
75% of Met carriers). Using questionnaires, we found no group difference with respect to 
depression, anxiety, sleep quality, and memory and cognitive complaints. Groups were not 
different in terms of PSG variables, including respiratory variables (Table 2). Finally, we 
found no significant group difference on cognitive screening tests, on the episodic memory 
variables used in the study (Table 3), and on other neuropsychological variables (i.e., 
Continuous Performance Test, Digit Span, verbal fluency, Color-Word Interference, and 
Tower of London).
Moderating effect of BDNF polymorphism on the association between sleep consolidation 
and memory
Hierarchical regression models showed that sleep interacts with BDNF polymorphism on 
both verbal memory tests (Table 4). In fact, BDNF polymorphism was found to have a 
significant moderating effect on the association between the sleep consolidation index and 
three of the four memory variables tested (RAVLT learning trials: β = −0.255, p < 0.006; 
RAVLT delayed recall: β = −0.258, p < 0.006; Logical Memory immediate recall: β = 
−0.371, p < 0.006; and a trend for Logical Memory delayed recall: β = −0.257, p = 0.0074, 
which was only a trend for significance when the Bonferroni correction was applied). These 
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moderating effects explained from 6.3% to 18.1% of the variance on the RAVLT and the 
Logical Memory subtest. A decomposition of significant interactions showed that, among 
Val/Val carriers, a higher sleep consolidation index was associated with better memory 
performance (RAVLT learning trials: β = 0.290, p = 0.01; RAVLT delayed recall: β = 0.306, 
p = 0.006; Logical Memory immediate recall: β = 0.434, p = 0.0001; Logical Memory 
delayed recall: β = 0.315, p = 0.01) and accounted for 7.4% to 16.5% of the variance. The 
significant interaction stemmed from the fact that these positive associations between sleep 
consolidation and memory performance were not observed among Met carriers. In fact, 
better sleep consolidation was associated with poorer memory performance on Logical 
Memory immediate recall in Met carriers (β = −0.585, p = 0.005; Fig. 1A) and explained 
28.7% of the variance. Trends for negative associations were also found between sleep 
consolidation and performance on RAVLT learning trials (β = −0.352, p = 0.07; Fig. 1B) and 
Logical Memory delayed recall (β = −0.392, p = 0.056).
No moderating effect of BDNF polymorphism on NREM SWA and total sleep time
NREM SWA was not associated with memory performance the next morning. Moreover, no 
significant interaction between BDNF polymorphism and NREM SWA power was observed. 
Analyses were conducted with total sleep time as an independent variable; no significant 
interaction with BDNF polymorphism was found to predict memory performance, although 
trends for significant effects were observed for RAVLT delayed recall (β = 0.216, p = 0.03) 
and Logical memory immediate recall (β = 0.174, p = 0.08). Independent of BDNF 
polymorphism, longer sleep duration was associated with better performance on both 
RAVLT and Logical Memory immediate recalls (β-values of 0.233 and 0.249, respectively; 
p = 0.01).
Cognitive domains other than memory
Supplementary analyses with other neuropsychological tests revealed that the BDNF Met 
allele selectively compromises the association between sleep and verbal memory with little 
effect on tasks involving the prefrontal cortex and no impact on other cognitive domains. 
Although trends for sleep (NREM SWA or sleep consolidation index) by BDNF 
polymorphism interaction were found for Digit Span, Trail Making Test part B, and Color-
Word Interference (time to complete Condition 3; p values <0.05, but >0.01), no significant 
interaction persisted when a correction for multiple testing was applied.
Discussion
Sleep consolidation and NREM SWA have been identified as having a crucial role in 
learning (Tartar et al., 2006; Yoo et al., 2007; Van Der Werf et al., 2009; Rolls et al., 2011; 
Wallace et al., 2015). In the present study, we observed that BDNF Val/ Met polymorphism 
moderates the association between memory and the sleep consolidation index, a variable 
integrating the number of awakenings, sleep efficiency, and the longest sleep bout. More 
specifically, we found that a night of consolidated sleep was associated with better learning 
abilities the next morning among Val/Val carriers. Our results confirm previous animal 
models showing the specific effect of sleep fragmentation on memory (Tartar et al., 2006; 
Rolls et al., 2011; Wallace et al., 2015). However, this positive sleep–memory association 
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was not observed among Met carriers. These results support the hypothesis that reduced 
activity-dependent secretion of BDNF impairs the benefits of sleep on synaptic plasticity 
and next-day memory.
Lower sleep consolidation is associated with better learning among Met carriers
Interestingly, for Logical Memory immediate recall in Met carriers, we observed that lower 
sleep consolidation was associated with better learning. This negative association was also 
found for the three other memory variables in Met carriers, but failed to reach significance (p 
value range from 0.056 to 0.15). This raises the question as to whether Met carriers see a 
benefit from increased sleep fragmentation (i.e., the number of awakenings during the night) 
in the form of improvements in their next-day memory performance. One explanation may 
be the use of an efficient compensatory cognitive strategy among Met carriers who 
experienced a poor night of sleep. In a rodent study, it was observed that sleep-deprived 
mice avoided the use of a hippocampus-dependent strategy to perform a memory task and 
instead used a striatum-dependent strategy (Hagewoud et al., 2010). In parallel, previous 
studies in elderly subjects have shown that Met carriers have more efficient or preserved 
frontostriatal functions than Val/Val individuals (Gajewski et al., 2012; Getzmann et al., 
2013). Although declarative memory was believed to mostly depend on hippocampus 
integrity, there is now compelling evidence that the striatum, along with the prefrontal 
cortex, may be involved (Scimeca and Badre, 2012). Our findings thus raise the intriguing 
possibility that poor sleep consolidation may have promoted the use of a striatum-dependent 
memory strategy that is potentially advantageous to Met carriers, who may have more 
efficient or better preserved frontostriatal functions than Val/Val individuals.
Another explanation might reside in a possible enhancement of BDNF expression during 
nighttime wakefulness. Indeed, BDNF mRNA expression has been reported to increase with 
acute prolonged wakefulness in rodents (Huber et al., 2007; El Helou et al., 2013). This 
increased BDNF expression may benefit next-day memory in the Met carriers who 
experienced frequent awakenings during their night of sleep. The negative association 
between sleep consolidation and memory was not observed among Val homozygotes, 
possibly because they already have abundant levels of BDNF. According to this hypothesis, 
a consolidated sleep will have more benefits in improving memory in Val/Val carriers, 
compared with Met allele carriers, because of their abundant levels of BDNF.
BDNF polymorphism is not a moderator of NREM SWA and memory association in middle-
aged and older individuals
Surprisingly, there was a lack of interaction between BDNF polymorphism and NREM 
SWA, suggesting that SWA plays the same role in next-day learning ability among Val/Val 
and Met carriers. However, we cannot exclude the idea that the lack of moderating effect 
may stem from our sample, which was made up of individuals between 55 and 84 years of 
age, a segment of the population known to experience less slow-wave sleep than younger 
adults (Carrier et al., 2001). In parallel, it was reported that Val/Val carriers had more slow-
wave sleep and more SWA than Met carriers (Bachmann et al., 2012), but another study 
failed to observe a group difference in their sleep characteristics (Mascetti et al., 2013). In 
rodents, BDNF injection over the hippocampus was also shown to increase SWA (Faraguna 
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et al., 2008). However, in the present study, we found that BDNF polymorphism had no 
effect on SWA. Again, this lack of a BDNF polymorphism group difference may be 
attributable to the fact that our participants were middle-aged or older adults.
The moderating effect of BDNF polymorphism is stronger for memory than for other 
cognitive functions
The moderating role of BDNF polymorphism in sleep consolidation was specific to episodic 
memory tasks. Although trends for significant moderating effects were found for tests 
mostly involving the prefrontal cortex, no significant interaction was observed for the other 
cognitive domains, reflecting that sleep by BDNF polymorphism interaction is more salient 
for hippocampus-dependent tasks than for other cognitive tasks. Concordant with this 
observation, a previous study of sleep deprivation failed to find a sleep by BDNF 
polymorphism interaction to explain working memory performance in young adults 
(Bachmann et al., 2012). Another study showed that Val/Val carriers have a greater increase 
in their performance in memorizing neutral faces learned before sleep than Met carriers, 
demonstrating that BDNF polymorphism interacts with sleep to explain overnight memory 
consolidation for a hippocampus-dependent task (Mascetti et al., 2013).
Sleep quality is a key element to understanding the effect of BDNF polymorphism on 
episodic memory
Our results explain some of the inconsistencies observed regarding the better performance of 
Val/Val carriers over Met carriers for episodic memory (Mandelman and Grigorenko, 2012). 
In fact, we showed that the enhanced performance of Val/Val carriers was observed only 
when subjects experienced a night of well consolidated sleep before learning. Thus, 
uncontrolled sleep quality preceding memory testing in previous studies may have led to 
heterogeneous results for the effect of BDNF polymorphism on episodic memory. The 
significant interaction between sleep consolidation and BDNF polymorphism may be an 
essential missing variable, particularly in middle-aged and older populations.
Strengths and limitations of the study
The strengths and limitations of this study relate mainly to the characteristics of our sample. 
The BDNF polymorphism groups were not different for all demographic variables 
(including education), subjective cognitive complaints, vascular burden, neuro-psychological 
performance, hippocampal volume, and APOE4 genotype. We can therefore assume that the 
groups were similar with respect to the proportion of individuals with preclinical dementia. 
Nonetheless, we cannot exclude the fact that some individuals might have been in a 
presymptomatic stage of dementia, and biomarkers such as positron emission tomography 
with the Pittsburgh Compound-B ligand would have been of great interest in our sample 
(Jack et al., 2016). Whether the neural consequences of chronic sleep fragmentation predict 
a further cognitive decline among older individuals is an interesting question that needs to be 
investigated with longitudinal studies that carefully track sleep history.
Our sample consisted mainly of men. Although sex was added as a control variable in our 
statistics, we should be cautious in extending the present findings to women. Another factor 
to consider is that 31% of our subjects were recruited from the waiting list for a sleep apnea 
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clinic, which means our sample included a higher proportion of individuals with sleep apnea 
(47.7% of our sample) than the 17% expected prevalence for men 50–70 years of age 
(Peppard et al., 2013). To control for the effect of obstructive sleep apnea, we included time 
spent with oxygen saturation <90% during sleep as a control variable in the regression 
analyses. Another limitation is the sample size of the Met carrier group, which was smaller 
than the Val/Val group. This lower proportion was nevertheless expected, given the 
frequency of the Met allele in the population (Egan et al., 2003). However, in the case of 
significant interactions, we reported R2 changes, which represent effect size and allow us to 
compare the associations observed for each group. Finally, the results of this study must be 
replicated with an independent sample, and a comparison of young versus older adults is the 
next step to understanding how BDNF polymorphism moderates the sleep–memory 
association.
Conclusions
Our work advances the field by revealing new evidence of genetic heterogeneity in how 
sleep consolidation contributes to learning ability. It reveals a complex, intricate relationship 
among sleep, BDNF polymorphism, and learning that merits further attention. This study 
confirms that better sleep consolidation is associated with better next-day learning in Val/Val 
individuals, who account for most of the population. However, our results also stress the 
importance of considering BDNF polymorphism when studying how sleep affects cognition, 
since the positive effect of sleep consolidation on memory was not found in Met carriers. 
Understanding the effect of the BDNF Met allele on specific components of a simple form 
of learning provides insight into the consequences of specific sleep disorders, particularly 
medical or neurodegenerative conditions that cause sleep fragmentation and memory 
dysfunction, such as obstructive sleep apnea (Gagnon et al., 2014) and Alzheimer’s disease 
(Widner et al., 2000). It is worth looking into whether sleep disorders have the same long-
term detrimental effects on brain health and cognition in BDNF Val/Val and Met carriers.
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Individuals with the BDNF Val/Val (valine allele) polymorphism showed better memory 
performance after a night of consolidated sleep. However, we observed that middle-aged 
and older individuals who are carriers of the BDNF Met allele displayed no positive 
association between sleep quality and their ability to learn the next morning. This 
interaction between sleep and BDNF polymorphism was more salient for hippocampus-
dependent tasks than for other cognitive tasks. Our results support the hypothesis that 
reduced activity-dependent secretion of BDNF impairs the benefits of sleep on synaptic 
plasticity and next-day memory. Our work advances the field by revealing new evidence 
of a clear genetic heterogeneity in how sleep consolidation contributes to the ability to 
learn.
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Sleep consolidation and memory performance for Val/Val and Met carriers. A, B, Fitted 
regression lines for Logical Memory: Story A immediate recall (A) and Rey Auditory Verbal 
Learning Test learning trials (B) according to sleep consolidation index in Val/Val (open 
gray circles) and Met carriers (black triangles). A higher sleep consolidation index 
represents a more consolidated sleep. Individual data points represent values adjusted for 
control variables (age, sex, education, time with oxygen saturation <90% during sleep).
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Table 1
Characteristics of Val/Val and Met carriers
Variables Val/Val carriers (n = 79) Met carriers (n = 28) t/χ2 values p values
Age (years) 63.5 ± 6.3 63.2 ± 6.5 0.2 n.s.
Male sex (%) 78.4 75 0.14 n.s.
Education (years) 15.8 ± 4.0 14.5 ± 2.8 1.8 n.s.
Body mass index (kg/m2) 27.0 ± 6.0 27.7 ± 3.9 −0.5 n.s.
Vascular Burden Index 1.3 ± 1.3 1.5 ± 1.3 −0.7 n.s.
Beck Depression Inventory 7.2 ± 5.3 5.9 ± 6.6 1.0 n.s.
Beck Anxiety Inventory 4.6 ± 4.4 4.2 ± 4.8 0.4 n.s.
Pittsburgh Sleep Quality Index 5.0 ± 3.2 5.7 ± 3.7 −1.0 n.s.
Epworth Sleepiness Scale 7.9 ± 4.7 9.0 ± 6.0 −1.0 n.s.
Insomnia Severity Index 7.0 ± 5.2 8.5 ± 5.8 −1.2 n.s.
Self-evaluation Questionnaire 1.5 ± 1.0 1.7 ± 1.0 −0.5 n.s.
Cognitive Failure Questionnaire 27.8 ± 12.2 30.0 ± 13.7 −0.8 n.s.
Right hippocampal volume (mm3) 3924.2 ± 456.1 4061.8 ± 413.1 −1.1 n.s.
Left hippocampal volume (mm3) 3736.2 ± 442.3 3890.9 ± 351.0 −1.4 n.s.
APOE (% with ε 4) 15 25 1.36 n.s.
Values are reported as the mean ± SD, unless otherwise indicated. n.s., not significant.
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Table 2
Sleep variables for Val/Val and Met carriers
Variables Val/Val carriers (n = 79) Met carriers (n = 28) t values p values
Stage N1 sleep (min) 81.4 ± 33.7 82.1 ± 41.7 −0.1 n.s.
Stage N2 sleep (min) 196.2 ± 53.1 192.8 ± 64.2 0.3 n.s.
Stage N3 sleep (min) 23.0 ± 26.2 31.6 ± 29.7 −1.4 n.s.
REM sleep (min) 53.5 ± 24.3 49.9 ± 23.0 0.7 n.s.
Total sleep time (min) 354.1 ± 66.6 356.3 ± 77.5 −0.2 n.s.
Number of awakenings 47.9 ± 20.1 45.3 ± 26.0 0.6 n.s.
Sleep efficiency (%) 76.8 ± 12.1 76.9 ± 13.0 −0.02 n.s.
Longest sleep bout (min) 55.8 ± 18.1 56.6 ± 20.9 −0.2 n.s.
Slow-wave activity power (μV2/30 s) 222.9 ± 112.1 260.0 ± 158.1 −1.3 n.s.
Apnea– hypopnea index 20.3 ± 17.1 18.9 ± 15.1 0.4 n.s.
Time with oxygen saturation <90% (min) 7.1 ± 15.2 13.3 ± 22.7 −1.6 n.s.
Values are reported as the mean ± SD. n.s., not significant.



















Gosselin et al. Page 20
Table 3
Neuropsychological results for Val/Val and Met carriers
Variables Val/Val carriers (n = 79) Met carriers (n = 28) t values p values
MoCA 27.8 ± 2.1 27.0 ± 2.2 1.7 n.s.
MMSE 28.7 ± 1.4 29.0 ± 0.9 −1.3 n.s.
RAVLT
 Learning trials (no. of words) 49.1 ± 10.2 47.1 ± 9.1 0.9 n.s.
 Delayed recall (no. of words) 9.5 ± 3.3 9.6 ± 3.1 0.02 n.s.
Logical Memory subtest of WMS-III
 Story A immediate recall 14.3 ± 3.8 14.7 ± 3.6 −0.5 n.s.
 Story A delayed recall 16.6 ± 3.5 17.6 ± 2.4 −1.4 n.s.
Values are reported as the mean ± SD. MoCA, Montreal Cognitive Assessment; MMSE, Mini Mental State Examination; WMS-III, Wechsler 
Memory Scale, third edition; n.s., not significant.
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